Phase 3 Study of Experience With a Gonadotropin-releasing Hormone Agonist Prior to Myomectomy - Comparison of 2 Versus 3 Monthly Doses.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Goserelin (Primary)
- Indications Uterine leiomyoma
- Focus Pharmacodynamics
- 26 Apr 2012 New trial record
- 20 Apr 2012 Biomarkers information updated